ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

RCEL Avita Medical Inc

8.65
0.25 (2.98%)
02 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Avita Medical Inc RCEL 나스닥 주식예탁증서 (DR)
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.25 2.98% 8.65 05:06:18
개장가 저가 고가 종가 전일 종가
8.41 8.4031 8.96 8.65 8.40
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
16/04/202406:05GLOBEAVITA Medical to Announce First Quarter 2024 Financial..
11/04/202406:11GLOBEAVITA Medical Updates Expected First Quarter 2024 Revenue
01/03/202406:02GLOBEAVITA Medical Submits Response to FDA, Resuming Review Clock..
29/02/202423:00GLOBEAVITA Medical to Present at TD Cowen 44th Annual Health Care..
23/02/202423:01GLOBEAVITA Medical to Host Investor Webinar Briefing
23/02/202406:02EDGAR2Form 8-K - Current report
23/02/202406:01GLOBEAVITA Medical Reports Fourth Quarter and Full-Year 2023..
02/02/202406:10GLOBEAVITA Medical to Announce Fourth Quarter and Full Year 2023..
11/01/202406:05EDGAR2Form 8-K - Current report
11/01/202406:01GLOBEAVITA Medical Announces Exclusive Distribution Agreement..
10/01/202423:01GLOBEAVITA Medical Announces Preliminary 2023 Financial..
06/01/202407:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/01/202423:00GLOBEAVITA Medical to Present at the 42nd Annual J.P. Morgan..
04/12/202323:00GLOBEAVITA Medical to Host Investor Webinar Briefing
22/11/202306:15GLOBEAVITA Medical to Present at the Piper Sandler 35th Annual..
21/11/202323:10IHMARKETNEWSKeep An Eye Out: Pre-Market Movers And Analyst..
21/11/202306:15GLOBEAVITA Medical Updates Full Year 2023 Guidance
10/11/202306:09EDGAR2Form 8-K - Current report
10/11/202306:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/11/202306:01GLOBEAVITA Medical Reports Third Quarter Financial Results with..
09/11/202323:00GLOBEAVITA Medical Announces Distribution Partnership with..
24/10/202305:36EDGAR2Form 8-K - Current report
20/10/202305:05GLOBEAVITA Medical to Announce Third Quarter 2023 Financial..
18/10/202322:07EDGAR2Form 8-K - Current report
18/10/202322:04EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
18/10/202322:00GLOBEAVITA Medical Announces Preliminary Third Quarter 2023..
02/10/202321:56EDGAR2Form 8-K - Current report
25/09/202321:00GLOBEAVITA Medical Receives Best Product Award at the American..
22/09/202305:30GLOBEAVITA Medical to Present at the Cantor Global Healthcare..
09/09/202306:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/09/202307:45GLOBEAVITA Medical to Participate in Upcoming Investor..
14/08/202321:00GLOBEAVITA Medical to Host Investor Webinar Briefing
11/08/202305:05EDGAR2Form 8-K - Current report
11/08/202305:01GLOBEAVITA Medical Reports Second Quarter Financial Results
21/07/202305:05GLOBEAVITA Medical to Announce Second Quarter 2023 Financial..
01/07/202305:27EDGAR2Form S-8 - Securities to be offered to employees in employee..
30/06/202307:21GLOBEAVITA Medical Submits FDA PMA Supplement for RECELL GO
26/06/202321:00GLOBEAVITA Medical Rejoins the Russell 3000 Index
17/06/202303:47GLOBEAVITA Medical Announces FDA Approval of RECELL for Skin..
16/06/202305:05GLOBEAVITA Medical Announces Appointment of David O’Toole as..
08/06/202309:00GLOBEAVITA Medical Announces FDA Approval of RECELL for Treatment..
16/05/202307:31GLOBEAVITA Medical to Host Investor Webinar Briefing
12/05/202305:12GLOBEAVITA Medical Reports First Quarter Financial Results and..

최근 히스토리

Delayed Upgrade Clock